Our analysis revealed that AMH levels were highest in healthy controls compared to those with local and systemic cancers (26), and among breast cancer patients prior to chemotherapy compared to during and after chemotherapy (at 1 month and at last available follow-up) (22) (Table 4). The gene discussed is AMH; the disease is breast carcinoma.